Summary
74 / 100 · Bulios Score
What speaks for it
- Out of every 100 SEK of revenue, 9.3 SEK is left as net profit.
- It has no debt and holds 2.32B kr in cash.
- The share price is below the Bulios Fair Price.
- It earns 11 SEK a year on every 100 SEK of invested capital.
What to watch
- Revenue fell by 4.6% a year over the last 3 years.
- 84% of profit goes to the dividend, leaving little room to raise it.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 14.3 SEK for 1 SEK of yearly profit.
Valuation in detailIs it growing?
It is shrinkingRevenue (SEK)
Diluted EPS (SEK)
- Analyst estimate
Revenue grew by 7.6% a year over 5 years. Over the last 3 years it fell by 4.6% a year. Earnings per share fell by 7.9% a year over the last 3 years.
Growth in detailDoes it make money?
Very wellWhere 100 SEK of revenue goes
- Cost of sales 79 SEK
- Sales and administration 7.8 SEK
- Taxes and other 3.9 SEK
- Net profit 9.3 SEK
Net profit, industry median (Chemicals - Specialty) 6.1 SEK
Out of every 100 SEK of revenue, 9.3 SEK is left as net profit.
Profitability in detailIs it financially healthy?
YesIt has no debt.
Financial health in detailDoes it pay a dividend?
High, stretched- Yield
- 5.88%
- Paid out of profit
- 84%
- Raised in a row
- 2 years
You receive $0.45 per share a year. The payout takes a large part of its profit or free cash flow.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.